Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire prepares to submit NDA for diquafosol by mid-2003

Jan. 14, 2003

Restasis receives FDA approval

Jan. 7, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Pfizer and Eyetech form collaboration to develop and commercialize Macugen

Dec. 30, 2002

Statistically significant preliminary results in Visudyne study in minimally classic wet AMD

Dec. 27, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

Advanced Biotherapy prepares IND for corneal transplant rejection therapy

Dec. 11, 2002

Phase II Posurdex trial in persistent macular edema completes enrollment

Dec. 11, 2002

INS-37217, a P2Y2 receptor agonist, enhances subretinal fluid reabsorption in preclinical models

Dec. 3, 2002

Asahi Glass patents new prostaglandin analogues with utility in glaucoma Rx

Dec. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...